Piyush Agarwal

Piyush Agarwal is a Professor in the Department of Surgery-Urology at the University of Chicago, specializing in urologic oncology with a focus on bladder cancer and genitourinary malignancies. He maintains an active research program centered on clinical trials, surgical outcomes, and therapeutic innovations in urologic cancers.

Dr. Agarwal's research focuses on multiple aspects of urologic oncology, including clinical trial design for bladder cancer therapies, surgical techniques for radical cystectomy, organ preservation strategies, and biomarker development. His work spans translational research with particular emphasis on targeted therapies and immunotherapies for advanced genitourinary tumors. He maintains collaborative relationships across multiple institutions for clinical trial consortia and has contributed to standardization of treatment protocols in urologic oncology.

Dr. Agarwal has an extensive publication record with recent articles demonstrating trends in immunotherapy clinical trials (particularly checkpoint inhibitors and combination therapies), surgical innovations in cystectomy techniques, and biomarker-driven treatment approaches. His work frequently addresses both clinical outcomes and methodological improvements in clinical trial design for urologic malignancies.

As an active clinical investigator, Dr. Agarwal contributes to multicenter trials through leadership roles and participates in expert consensus panels developing best practice guidelines for urologic cancer management and tissue procurement standards in oncology research.